Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
24.84
+0.43 (1.76%)
At close: Apr 28, 2026, 4:00 PM EDT
24.84
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:42 PM EDT

Company Description

Privia Health Group, Inc. operates as a national physician-enablement company in the United States.

The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives.

In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs.

The company was founded in 2007 and is headquartered in Arlington, Virginia.

Privia Health Group, Inc.
Privia Health Group logo
Country United States
Founded 2007
IPO Date Apr 29, 2021
Industry Health Information Services
Sector Healthcare
Employees 1,226
CEO Parth Mehrotra

Contact Details

Address:
950 North Glebe Road, Suite 700
Arlington, Virginia 22203
United States
Phone 571 366 8850
Website priviahealth.com

Stock Details

Ticker Symbol PRVA
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.00
CIK Code 0001759655
CUSIP Number 74276R102
ISIN Number US74276R1023
SIC Code 8000

Key Executives

Name Position
Parth Mehrotra Chief Executive Officer and Director
David Mountcastle CPA, MBA Executive Vice President and Chief Financial Officer
Edward Christopher Fargis Esq. Executive Vice President, General Counsel, Chief Legal Officer and Corporate Secretary
Sarath Degala Chief Operating Officer

Latest SEC Filings

Date Type Title
Apr 2, 2026 144 Filing
Apr 2, 2026 ARS Filing
Apr 2, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 2, 2026 DEF 14A Other definitive proxy statements
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 16, 2026 144 Filing
Mar 16, 2026 144 Filing
Mar 13, 2026 144 Filing
Mar 13, 2026 144 Filing
Mar 12, 2026 144 Filing